Despite continuous endeavors to generate more efficacious pharmaceuticals, the significance of GPR40 in the pathophysiology of Alzheimer’s disease renders it a promising candidate for therapeutic discovery and development. The gene discussed is FFAR1; the disease is early-onset autosomal dominant Alzheimer disease.